September 2010

TABLE OF CONTENTS

Looking for Gorillas

Derek G. Hennecke, MBA, continues with part 4 of this 6-part series on business models and best practices for navigating the new normal.

 

Decade in Review – Drug Delivery Product Sales

Josef Bossart, PhD, believes that to better understand where product opportunities are headed, it’s worth reviewing product sales for drug delivery enabled/enhanced products (DDEP) throughout the past decade.  

 

Injecting Hand-Held Delivery Devices Into the Home

In this annual report on the hand-held injection market, Contributor Cindy H. Dubin spoke with several industry players about the rise in home healthcare, the opportunities for innovative injectable delivery options, and how companies can differentiate their products in what is expected to become a highly competitive market.

 

Nanoparticulate Carrier Drug Delivery Systems: A Mini Review of Patented Technologies

Avani Amin, MPharm, PhD; and Mohit Shah, MPharm; compile some patented nanocarrier-based drug delivery technologies marketed by pharma giants and highlight their applications and express their novelty.

 

Controlled Release of Cinnarizine Using Gastro-Retentive Emugel Beads of Calcium Alginate

Bhupendra G. Prajapati, MPharm; Rakesh P. Patel, PhD, MPharm; and Kalpesh L. Vaghasia, MPharm; develop gastro-retentive emulsion gel (EMG) beads of calcium alginate capable of floating in the gastric environment using an emulsion-gelation method, and investigate their release properties.

 

ISP Pharmaceuticals: Addressing Drug Solubility Challenges & Energizing the Drug Commercialization Process

Drug Delivery Executive: Philip Strenger, Senior Vice President – Global Pharmaceuticals for ISP, talks about the new Drug Solubility Initiative and his business’ approach to helping the pharmaceutical industry rapidly and economically commercialize drugs based on poorly soluble actives.

 

Packaging’s Role in the Pharma Space: Meeting the Needs of Global Consumers

Drug Delivery Executive: Dr. Ted Lithgow, President of MWV Healthcare, discusses how healthcare packaging is becoming increasingly sophisticated and innovative, while sharing insights on packaging as a critical tool to address poor medication adherence.

 

ANTISENILIN^® Monoclonal Antibody Platform to Prevent Accumulation & Neurotoxicity of Aβ in Alzheimer’s Brain

Daniel G. Chain, PhD, indicates this platform has gained considerable momentum throughout the past few years, and leading experts have expressed optimism that drugs being developed using this proprietary patented technology herald an exciting new era of drug development.

 

Amira Pharmaceuticals: Creating High-Value Compounds

Executive Summary: CSO and Co-Founder Peppi Prasit, PhD, discusses how Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient and effective preclinical and clinical program decisions.

 

DEPARTMENTS

 

Market News & Trends

 

Attorney Review    

Patent Procurement – Fast Tracking to Protection

 

Technology Showcase

 

External Delivery

The Mystery of Private Equity Firms

 

COVER

FEATURES